TBXU holdings: all 8 positions
TBXU held swaps on BIOEW5 worth 146.3% of its net assets on Oct 22, 2026. With the 53.7% it holds directly, its exposure is 200.0%.
Every position
| # | Holding | Tracks | Weight ↓ |
|---|---|---|---|
| 1 | BIOEW5 swap asset leg | BIOEW5 | 58.11% |
| 2 | BIOEW5 swap asset leg | BIOEW5 | 45.44% |
| 3 | BIOEW5 swap asset leg | BIOEW5 | 42.78% |
| 4 | Amgen Inc | 12.10% | |
| 5 | Gilead Sciences Inc | 11.17% | |
| 6 | Regeneron Pharmaceuticals | 10.73% | |
| 7 | Vertex Pharmaceuticals Inc | 10.62% | |
| 8 | Argenx SE - ADR | 9.06% | |
| Dreyfus Govt Cash Man Ins | 24.56% | ||
| Goldman Finl Sq Trsry Inst 506 | 13.89% | ||
| Goldman Sachs Fin Gov 465 Institut | 5.71% |
Source: Direxion’s daily holdings file. Data as of Oct 22, 2026. Updated each trading day. Report a data error
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. A swap line’s weight is the exposure it gives the fund, not money the fund paid. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. A swap’s Tracks column is the name its line gives what it is written on. Names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of TBXU, data as of Oct 22, 2026. https://etfiq.com/funds/tbxu/holdings/
ETFIQ. (Oct 22, 2026). Holdings of TBXU. Retrieved from https://etfiq.com/funds/tbxu/holdings/
[Holdings of TBXU (ETFIQ, Oct 22, 2026)](https://etfiq.com/funds/tbxu/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.